PUMA BIOTECHNOLOGY, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $229.0M | $226.6M | $63.1M |
| FY2022 | $200.5M | $222.1M | $76.2M |
| FY2023 | $177.1M | $230.5M | $84.6M |
| FY2024 | $121.2M | $213.3M | $69.2M |
| FY2025 | $86.0M | $216.3M | $29.6M |